Posted by kalkgrun on 12th of Feb 2021 at 11:38 am
Its moved a bunch but Dermtech DMTK just signed a deal with Blue
Cross of Texas for their skin cancer test.
https://dermtech.com/
Projecting $10B in sales.
"Melanoma is deadly if not caught early. But it’s very difficult
to visually detect. So it’s no wonder that the status quo was to
biopsy any mole that looks remotely suspicious. That leads to a lot
of cutting. But not a lot of accuracy — 96% of biopsies taken test
negative for melanoma.* And 17% of the time, early stage melanoma
is missed altogether. Now, there’s a step before the scalpel.
The DermTech Melanoma Test is extremely accurate, with a 99%
negative predictive value (that is, a 99% probability that a
negative test means you really don’t have the disease)."
Newsletter
Subscribe to our email list for regular free market updates
as well as a chance to get coupons!
Its moved a bunch but
Posted by kalkgrun on 12th of Feb 2021 at 11:38 am
Its moved a bunch but Dermtech DMTK just signed a deal with Blue Cross of Texas for their skin cancer test. https://dermtech.com/ Projecting $10B in sales.
"Melanoma is deadly if not caught early. But it’s very difficult to visually detect. So it’s no wonder that the status quo was to biopsy any mole that looks remotely suspicious. That leads to a lot of cutting. But not a lot of accuracy — 96% of biopsies taken test negative for melanoma.* And 17% of the time, early stage melanoma is missed altogether. Now, there’s a step before the scalpel. The DermTech Melanoma Test is extremely accurate, with a 99% negative predictive value (that is, a 99% probability that a negative test means you really don’t have the disease)."